These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6287387)

  • 1. [Clinical study of ceftriaxone (author's transl)].
    Lafaix C; Beucler A; Soussy CJ; Dublanchet A
    Pathol Biol (Paris); 1982 Jun; 30(6):349-52. PubMed ID: 6287387
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ceftriaxone in septic processes].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1983 Oct; 171(2):103-5. PubMed ID: 6318279
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)].
    Guibert J; Coppens H; Yvelin C
    Pathol Biol (Paris); 1982 Jun; 30(6):353-6. PubMed ID: 6287388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone sodium (Rocephin).
    Med Lett Drugs Ther; 1985 Apr; 27(686):37-9. PubMed ID: 3887114
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
    Steele RW
    Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182
    [No Abstract]   [Full Text] [Related]  

  • 7. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftriaxone, a third generation cephalosporin.
    Johnson ES; Fedder M; Smith LG
    J Med Soc N J; 1984 Nov; 81(11):941-4. PubMed ID: 6096548
    [No Abstract]   [Full Text] [Related]  

  • 10. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of ceftriaxone in the field of gynecology].
    Murata M; Ota H; Soga K; Maki M
    Jpn J Antibiot; 1985 Jan; 38(1):1-3. PubMed ID: 3989968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on ceftriaxone in the field of obstetrics and gynecology].
    Murakami M; Deguchi H; Masuzaki H; Yamabe T
    Jpn J Antibiot; 1985 Jan; 38(1):13-7. PubMed ID: 3989973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on ceftizoxime in children (author's transl)].
    Kobayashi Y; Haruta T; Tsutsui T; Kuroki S; Okura K; Tsuji S; Ouchi T; Yamakawa M
    Jpn J Antibiot; 1982 Jan; 35(1):137-51. PubMed ID: 6279905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Third generation cephalosporins in severe infections in children].
    Havlík J; Maresová V
    Cesk Pediatr; 1985 Mar; 40(3):163-5. PubMed ID: 4005990
    [No Abstract]   [Full Text] [Related]  

  • 15. [The activity and tolerance of ceftriaxone in the treatment of severe surgical infections].
    Erttmann M
    Wien Med Wochenschr Suppl; 1985; 87():32-5. PubMed ID: 3856975
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of ceftriaxone (1 g single dose) versus cefotaxime (three 1 g doses) for gynecologic and obstetric infections.
    Gerstner GJ
    J Chemother; 1989 Jul; 1(4 Suppl):884-6. PubMed ID: 16312686
    [No Abstract]   [Full Text] [Related]  

  • 17. Twice daily ceftriaxone therapy for serious bacterial infections in children.
    Chonmaitree T; Congeni BL; Munoz J; Rakusan TA; Powell KR; Box QT
    J Antimicrob Chemother; 1984 May; 13(5):511-6. PubMed ID: 6330022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ceftriaxone (Rocéphine) in major African infectious pathology. Results at the Niamey Hospital (Niger) ].
    Rey JL; Konarjevski R; Madras R; Ousseini A; Félix H
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):513-6. PubMed ID: 6289228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone: a long-acting cephalosporin.
    Am J Med; 1984 Oct; 77(4C):1-118. PubMed ID: 6093510
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceftriaxone therapy of serious bacterial infections.
    Eron LJ; Park CH; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.